CLT-009

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCLT-009
Drug Alias NameCLT-009
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsAngiogenesis disorderMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCharlesson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCharlesson
Active IndicationsN/A
Inactive IndicationsAngiogenesis disorderMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A